$ANVI
ANVI GLOBAL HOLDINGS, INC.

2024 Q2 Form 10-K Financial Statement

#000107997324000814 Filed on May 24, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2024
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $55.10K $47.55K
YoY Change -24.51%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $55.10K $47.55K $199.4K
YoY Change 2.64% -24.51% -13.86%
Operating Profit -$55.10K -$199.4K
YoY Change 2.64% -13.86%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 -$14.05K $14.05K
YoY Change -100.0%
Pretax Income -$55.10K -$47.55K -$185.4K
YoY Change 39.04% -24.51% -19.93%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$55.10K -$47.55K -$185.4K
YoY Change 39.04% -24.51% -19.93%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 120.0M shares 120.0M shares 120.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.980K $1.330K $1.330K
YoY Change -15.29% -15.29%
Cash & Equivalents $7.978K $1.334K
Short-Term Investments
Other Short-Term Assets $9.100K $13.00K $13.00K
YoY Change 4.0% 4.0%
Inventory
Prepaid Expenses $9.100K $13.00K
Receivables
Other Receivables
Total Short-Term Assets $17.08K $14.33K $14.33K
YoY Change 88.75% 1.9% 1.85%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $17.08K $14.33K $14.33K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $17.08K $14.33K $14.33K
YoY Change 88.75% 1.9% 1.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.10K $21.76K $525.8K
YoY Change -1.54% -55.5% 28.58%
Accrued Expenses $900.0K $900.0K $900.0K
YoY Change 0.0% 0.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.032M $1.975M $1.975M
YoY Change 11.45% 10.38% 10.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.032M $1.975M $1.975M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.032M $1.975M $1.975M
YoY Change 11.45% 10.38% 10.38%
SHAREHOLDERS EQUITY
Retained Earnings -$2.074M -$2.019M
YoY Change 10.72% 10.11%
Common Stock $58.50K $58.50K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.015M -$1.960M -$1.960M
YoY Change
Total Liabilities & Shareholders Equity $17.08K $14.33K $14.33K
YoY Change 88.75% 1.9% 1.85%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2024
OPERATING ACTIVITIES
Net Income -$55.10K -$47.55K -$185.4K
YoY Change 39.04% -24.51% -19.93%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$9.856K -$4.670K -$69.02K
YoY Change -53.63% -83.47% -15.33%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $16.50K 5.250K $68.79K
YoY Change -17.44% -80.65% -9.72%
NET CHANGE
Cash From Operating Activities -$9.856K -4.670K -$69.02K
Cash From Investing Activities $0.00 0.000 $0.00
Cash From Financing Activities $16.50K 5.250K $68.79K
Net Change In Cash $6.644K 580.0 -$233.00
YoY Change -623.56% -151.79% -95.62%
FREE CASH FLOW
Cash From Operating Activities -$9.856K -$4.670K -$69.02K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001570132
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-02-29
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-29
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 319-4
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Cary
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27511
CY2024 dei City Area Code
CityAreaCode
408
CY2024 dei Local Phone Number
LocalPhoneNumber
821-4491
CY2024 dei Security12g Title
Security12gTitle
Common Stock, $.001 par value
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
Yes
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
119950000 shares
CY2024Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2024 dei Auditor Name
AuditorName
Fruci & Associates II, PLLC
CY2024 dei Auditor Location
AuditorLocation
Spokane, WA
CY2024 dei Auditor Firm
AuditorFirmId
5525
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1334 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1567 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12500 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
14334 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
14067 usd
CY2024Q1 us-gaap Assets
Assets
14334 usd
CY2023Q1 us-gaap Assets
Assets
14067 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
21761 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
48904 usd
CY2024Q1 ANVI Accounts Payable Related Party
AccountsPayableRelatedParty
504000 usd
CY2023Q1 ANVI Accounts Payable Related Party
AccountsPayableRelatedParty
360000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
900000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
900000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
548805 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
480020 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1974566 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1788924 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1974566 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1788924 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
119950000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119950000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
119950000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119950000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
119950 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
119950 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
-61450 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
-61450 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2018732 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1833357 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1960232 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1774857 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14334 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14067 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
199426 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
231503 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
199426 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
231503 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-199426 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-231503 usd
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
14051 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14051 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-185375 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-231503 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-185375 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-231503 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119950000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119950000 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1543354 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-231503 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1774857 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-185375 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1960232 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-185375 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-231503 usd
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
14051 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
CY2024 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
500 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
650 usd
CY2024 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-13092 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6639 usd
CY2024 ANVI Increase Decrease In Accounts Payable Related Party
IncreaseDecreaseInAccountsPayableRelatedParty
144000 usd
CY2023 ANVI Increase Decrease In Accounts Payable Related Party
IncreaseDecreaseInAccountsPayableRelatedParty
144000 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-69018 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-81514 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
68785 usd
CY2023 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
76190 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
68785 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
76190 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-233 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5324 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1567 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6891 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1334 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1567 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zdYywbBNVBD1" style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86B_zE8vbgvZLKRl">Use of Estimates</span></span></i></p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.</p> <p style="font: 10pt/11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p>
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zxCEl816H0F5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span style="text-decoration: underline"><span id="xdx_86B_zZlgazBZ6FEk">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
385000 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
424000 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
385000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2018732 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12500 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
900000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
900000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
548805 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
480020 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
424000 usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
39000 usd
CY2023 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
49000 usd
CY2024 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
39000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
49000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
424000 usd
CY2024 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001079973-24-000814-index-headers.html Edgar Link pending
0001079973-24-000814-index.html Edgar Link pending
0001079973-24-000814.txt Edgar Link pending
0001079973-24-000814-xbrl.zip Edgar Link pending
anvi-20240229.xsd Edgar Link pending
anvi_10k.htm Edgar Link pending
ex31x1.htm Edgar Link pending
ex32x1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
anvi-20240229_cal.xml Edgar Link unprocessable
anvi-20240229_lab.xml Edgar Link unprocessable
anvi-20240229_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
anvi_10k_htm.xml Edgar Link completed
Show.js Edgar Link pending
anvi-20240229_def.xml Edgar Link unprocessable